SHANGHAI, Sept. 25, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other ...
SHANGHAI, Sept. 25, 2023 /PRNewswire/ -- Zhongchao Inc. (ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major ...
SHENZHEN, China, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leader in AI-driven Internet healthcare solutions, was presented with a Generative AI ...
It can be challenging to identify which patients with advanced chronic kidney disease (CKD) will most benefit from ...
Qureight’s Vascul8 model has been validated in a peer-reviewed study marking a significant advance in the treatment of ...
Researchers developed and validated a model that estimates individualized survival probabilities with conservative management versusdialysis in patients with advanced chronic kidney disease.